This page lists cancer drugs approved by the Food and Drug Administration (FDA) for melanoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in melanoma that are not listed here.
Drugs Approved for Melanoma
- Aldesleukin
- Amtagvi (Lifileucel)
- Atezolizumab (Tecentriq)
- Atezolizumab and Hyaluronidase-tqjs
- Binimetinib
- Braftovi (Encorafenib)
- Cobimetinib Fumarate
- Cotellic (Cobimetinib Fumarate)
- Dabrafenib Mesylate
- Dacarbazine
- Encorafenib
- Hepzato (Melphalan Hydrochloride)
- IL-2 (Aldesleukin)
- Imlygic (Talimogene Laherparepvec)
- Interleukin-2 (Aldesleukin)
- Intron A (Recombinant Interferon Alfa-2b)
- Ipilimumab
- Keytruda (Pembrolizumab)
- Kimmtrak (Tebentafusp-tebn)
- Lifileucel
- Mekinist (Trametinib Dimethyl Sulfoxide)
- Mektovi (Binimetinib)
- Melphalan Hydrochloride
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Nivolumab and Relatlimab-rmbw
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Opdualag (Nivolumab and Relatlimab-rmbw)
- Pembrolizumab
- Proleukin (Aldesleukin)
- Recombinant Interferon Alfa-2b
- Tafinlar (Dabrafenib Mesylate)
- Talimogene Laherparepvec
- Tebentafusp-tebn
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
- Trametinib Dimethyl Sulfoxide
- Vemurafenib
- Yervoy (Ipilimumab)
- Zelboraf (Vemurafenib)